Trials / Completed
CompletedNCT00971022
Discount Generic Prescription Study
Discount Generic Prescription Utilization in Low-income Populations
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 574 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs. The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.
Detailed description
If you agree to take part in this study, you will take part in a focus group. The focus group will consist of about 8 people who will discuss beliefs about generic medication, awareness of discount generic prescription programs, and use of the discount generic prescription program. The focus group will last about 90 minutes. During the focus group, you will complete a form that asks for basic demographic information (such as your age and sex). The focus group discussions will be taped, and the recorded tapes will be transcribed word-for-word. The taped recording of the focus group study will be stored in a safe and secured locker by the study chair. The taped recordings will be destroyed after 5 years. Length of Study: Your participation on this study will end once you complete the focus group. This is an investigational study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Survey | 20 minute survey to determine the relationship between awareness of the discount generic prescription program and utilization of the program. |
| BEHAVIORAL | Focus Group | 5 - 8 focus groups of 6 - 10 people, lasting approximately 90 minutes |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2009-09-03
- Last updated
- 2012-04-18
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00971022. Inclusion in this directory is not an endorsement.